Suchergebnisse - "Hao, Wei"

PubPharm (28)

1

Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure

enthalten in: Transplantation and cellular therapy | 2023

von Holland, E. | Yates, B. | Steinberg, S. | +13

2

Circulating CD22+/CD19-/CD24- progenitors and CD22+/CD19+/CD24- mature B cells : Diagnostic pitfalls for minimal residual disease detection in B-lymphoblastic leukemia

enthalten in: Cytometry. Part B, Clinical cytometry | 2023

von Zhou, T. | Karrs, J. | Ho, T. | +5

3

CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity

enthalten in: Journal for immunotherapy of cancer | 2023

von Jess, J. | Yates, B. | Dulau-Florea, A. | +18

4

Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis

enthalten in: The American journal of surgical pathology | 2023

von Obiorah, I. | Karrs, J. | Brown, L. | +8

5

A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions

enthalten in: British journal of haematology | 2023

von Zhou, T. | Yuan, C. | Lurain, K. | +14

CommentIn: Br J Haematol. 2023 Feb;200(4):401-403. - PMID 36397674

6

Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy

enthalten in: Blood advances | 2022

von Holland, E. | Yates, B. | Ling, A. | +11

7

Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells

enthalten in: Blood | 2021

von Lichtenstein, D. | Schischlik, F. | Shao, L. | +28

8

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant

enthalten in: Blood advances | 2021

von Chihara, D. | Arons, E. | Stetler-Stevenson, M. | +15

9

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma : A Phase 2 Nonrandomized Controlled Trial

enthalten in: JAMA oncology | 2021

von Kazandjian, D. | Hill, E. | Dew, A. | +31

10

Antigen Loss after Targeted Immunotherapy in Hematological Malignancies

enthalten in: Clinics in laboratory medicine | 2021

von Zhou, T. | Wang, H.